These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1280430)

  • 21. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
    Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
    J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the putative E2 protein of hepatitis C virus in human liver.
    Nakamoto Y; Kaneko S; Honda M; Unoura M; Cheong J; Harada A; Matsushima K; Kobayashi K; Murakami S
    J Med Virol; 1994 Apr; 42(4):374-9. PubMed ID: 7519251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera.
    Morii K; Shimomura H; Nakagawa H; Hasui T; Tsuji T
    Acta Med Okayama; 1992 Aug; 46(4):285-93. PubMed ID: 1332424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.
    Brillanti S; Masci C; Ricci P; Miglioli M; Barbara L
    Hepatology; 1992 Jun; 15(6):998-1001. PubMed ID: 1317344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
    Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
    Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
    Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
    Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymerase chain reaction in detecting hepatitis C virus among blood donors.
    Mosley JW; Nowicki MJ; Wang LF; Laskus T; Rakela JL
    Dev Biol (Basel); 2000; 102():93-6. PubMed ID: 10794094
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.
    Mita E; Hayashi N; Ueda K; Kasahara A; Fusamoto H; Takamizawa A; Matsubara K; Okayama H; Kamada T
    Biochem Biophys Res Commun; 1992 Mar; 183(3):925-30. PubMed ID: 1314578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between detection of anti-viral antibody and histopathological disease activity in an epidemic of hepatitis C.
    Fukuda Y; Nagura H; Takayama T; Imoto M; Shibata M; Kudo T; Morishima T; Miyamura T; Nagai Y
    Arch Virol; 1992; 126(1-4):171-8. PubMed ID: 1381909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.
    Yang PM; Hwang LH; Lai MY; Huang WL; Chu YD; Chi WK; Chiang BL; Kao JH; Chen PJ; Chen DS
    Clin Exp Immunol; 1995 Aug; 101(2):272-7. PubMed ID: 7544249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of serum hepatitis C virus RNA using the polymerase chain reaction assay].
    Yanagi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1991 Feb; 49(2):292-9. PubMed ID: 1849185
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Ohkawa K; Fusamoto H; Kamada T
    Hepatology; 1994 Jun; 19(6):1360-5. PubMed ID: 7514560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.
    Orito E; Mizokami M; Mizoguchi N; Ohba K; Tohnai M; Yamanaka H; Oguri T; Hirashima N; Koide T; Kano H
    J Hepatol; 1994 Jul; 21(1):130-2. PubMed ID: 7525694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody pattern's lack of predictivity in determining the response of viral hepatitis C to interferon therapy.
    Berardo C; Gerardi R; Delle Monache M; Del Vecchio S; Ricci GL
    Ital J Gastroenterol; 1994; 26(8):398-400. PubMed ID: 7535599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on the patterns of early specific antibody response in patients with posttransfusion hepatitis C].
    Hao F; Li MD
    Zhonghua Nei Ke Za Zhi; 1994 Sep; 33(9):593-6. PubMed ID: 7536148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion and purification of hepatitis C virus NS1 glycoprotein produced by recombinant baculovirus-infected insect cells.
    Nishihara T; Nozaki C; Nakatake H; Hoshiko K; Esumi M; Hayashi N; Hino K; Hamada F; Mizuno K; Shikata T
    Gene; 1993 Jul; 129(2):207-14. PubMed ID: 7686870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.